XTalks

FEBRUARY 8, 2024

Diabetes remains a critical global challenge, affecting millions of lives and commanding significant attention from the medical, life sciences and pharmaceutical sectors. Read on to learn more about the top 15 diabetes drugs in 2023, based on 2022 sales statistics. mL subcutaneous solution (2 mg/1.5 billion in Q4 2022.

Sales 52

Sales Insulin FDA Approval Drugs 52

The Pharma Data

JANUARY 5, 2021

Novasep’s division expects to generate sales revenue of approximately 37 million euros in 2020 at double-digit profit margins and employs approximately 100 people, the majority of whom work at its Pompey site in northern France and some in the USA , China and India. 6,200 people, and earned sales revenue of 1,440.6 million euros.

Manufacturing 52

Manufacturing Sales Contract Manufacturing Insulin 52

Pharma in Brief

AUGUST 9, 2021

Individual standards for certain biologic drugs ( e.g. , insulin) would be repealed in favor of relying on the standards set out in Schedule B to the Food and Drugs Act. The amendments contemplate labelling flexibilities for special containers.

Regulation 98

Regulation Drugs Manufacturing Production 98

XTalks

NOVEMBER 9, 2022

Since Mounjaro’s May US Food and Drug Administration (FDA) approval, sales of the drug have skyrocketed beyond initial expectations owing to patient demand and a temporary shortage of Novo’s Ozempic. dependent insulin secretion and suppression of glucagon release. And the demand won’t be easing anytime soon. mediated glucose?dependent

Insulin 98

Insulin Hormones FDA Approval Sales 98

XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. It contains the antiviral medications nirmatrelvir and ritonavir. billion in pharmaceutical sales from 2021. RELATED: Top 10 Medical Device Companies in 2023: Statistics and Trends 1) Pfizer By: Nadia Stec, M.Sc. billion, a 42.74

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

JANUARY 5, 2021

6, 2021 /PRNewswire/ — The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep. . In fiscal 2019, the company earned sales revenue of some 1.83 About Sartorius. billion euros.

Life Science 52

Life Science Manufacturing Sales Contract Manufacturing 52